ICU Map
hematology / oncology

Acute Bleeding & Falling Hemoglobin

Bedside triage of acute blood loss: active hemorrhage vs occult bleeding vs hemodilution, context-specific RBC thresholds, protocolized massive-hemorrhage resuscitation, targeted component therapy, and anticoagulant reversal.

An acute drop in hemoglobin (Hb drop ≥ 2.0 g/dL in 24 hours) or overt clinical bleeding in the ICU requires immediate triage across three critical domains: (1) Hemodynamic stability and tissue perfusion; (2) Distinguishing active hemorrhage from occult bleeding, hemodilution, or acute hemolysis; and (3) Rapid identification of the bleeding source, coagulation status, and anticoagulant reversal.

Caution

Dangerous Diagnosis Not to Miss: Exsanguinating Upper GI Bleeding (ruptured esophageal varices / bleeding peptic ulcer), Massive Retroperitoneal Hematoma (especially post-femoral arterial/venous catheterization or pelvic trauma; can hold 2–3 liters of blood with zero external signs), Intra-Abdominal Hemorrhage, and Trauma-Induced / Sepsis-Induced DIC.

1

RECOGNIZE & INITIAL SAFETY SCREEN

  • Overt Bleeding Signs: Hematemesis, melena, bright red blood per rectum (hematochezia), hemoptysis, surgical drain bleeding (> 100–200 mL/hr), spontaneous oozing from line sites or venipunctures.

  • Occult Bleeding Clues: Unexplained tachycardia, acute hypotension, increasing vasopressor requirements, rising serum lactate, abdominal distension / rising intra-abdominal pressure, flank ecchymosis (Grey Turner sign), periumbilical ecchymosis (Cullen sign).

  • Hemodilution vs True Loss: Massive crystalloid fluid administration drops hemoglobin purely by hemodilution without tissue hypoxia; true acute hemorrhage is accompanied by tachycardia, narrowing pulse pressure, and elevated shock index (HR / SBP > 0.9–1.0).

2

MASSIVE TRANSFUSION PROTOCOL (MTP) VS RESTRICTIVE TRANSFUSION

  • Massive Hemorrhage:

    • Activate the local massive-hemorrhage/MTP protocol early when bleeding is life-threatening or rapid ongoing transfusion is expected; prioritize definitive hemorrhage control, warming, ionized-calcium monitoring/replacement, and rapid laboratory/viscoelastic reassessment.
    • Trauma: Early balanced component resuscitation is reasonable. PROPPR compared 1:1:1 with 1:1:2 and improved hemostasis/reduced exsanguination, but did not significantly improve the trial's overall 24-hour or 30-day mortality endpoints; do not present 1:1:1 as a universal strict ratio for every hemorrhage phenotype.
    • Fibrinogen: Replace clinically important hypofibrinogenemia using cryoprecipitate or fibrinogen concentrate according to local protocol and laboratory/viscoelastic results; target ranges depend on the bleeding context rather than one universal number.
    • Calcium/Temperature/Acid-Base: Monitor ionized calcium during major transfusion and treat clinically important hypocalcemia; prevent hypothermia and severe acidemia while achieving source control.

  • Non-Massive / Hemodynamically Stable Anemia:

    • For most stable hospitalized/ICU adults, AABB 2023 recommends a restrictive strategy, considering RBC transfusion when Hb <7 g/dL while incorporating symptoms, active ischemia, ongoing bleeding, comorbidity and patient factors.
    • Acute MI/ACS is different: the 2025 ACC/AHA ACS guideline states that RBC transfusion to maintain Hb around 10 g/dL may be reasonable in ACS with acute or chronic anemia when not actively bleeding (Class 2b); do not automatically apply the general ICU <7 g/dL threshold.
3

TARGETED DIFFERENTIAL BY BLEEDING SITE

  • Gastrointestinal Bleeding: Upper GI (peptic ulcer, esophageal/gastric varices, Dieulafoy lesion, Mallory-Weiss tear); Lower GI (diverticulosis, angiodysplasia, ischemic colitis, post-polypectomy).

  • Retroperitoneal & Pelvic: Post-femoral vascular access cannulation, spontaneous retroperitoneal hemorrhage in anticoagulated patients, pelvic ring fractures.

  • Surgical & Thoracic: Anastomotic disruption, surgical bed bleeding, hemothorax, mediastinal hemorrhage post-cardiac surgery.

  • Intracranial: Hemorrhagic stroke, traumatic subdural/epidural hematoma.

  • Diffuse Microvascular / Consumptive: Disseminated Intravascular Coagulation (DIC), hypofibrinogenemia, severe thrombocytopenia.

4

EMERGENCY ANTICOAGULANT REVERSAL PROTOCOLS

5

DEFINITIVE EMERGENCY SOURCE CONTROL

Caution

Common Diagnostic Trap: Relying on initial hemoglobin/hematocrit levels to judge the severity of acute massive hemorrhage. In sudden acute exsanguination, whole blood is lost equally; hemodilution occurs only after hours of fluid shifts or crystalloid resuscitation. A patient bleeding to death can have an initial hemoglobin of 14.0 g/dL; vital signs, shock index, and clinical blood loss must guide transfusion.

Destination Topics

  • Transfusion: TRICC trial, restrictive thresholds, massive transfusion protocols, and TRALI/TACO risks.

  • Upper GI Bleed: Glasgow-Blatchford score, variceal banding, octreotide, and endoscopic techniques.

  • DIC: Consumptive coagulopathy, ISTH scoring, and cryoprecipitate repletion.

  • Anticoagulation: Direct oral anticoagulant reversal agents and laboratory assays.

  • Shock: Hemorrhagic shock physiology and resuscitation endpoints.

  • Intra-Abdominal Hypertension: Abdominal compartment syndrome in massive transfusion.

Evidence status

Review metadata not yet recorded.

Status, review dates and guideline versions appear here once editorial metadata is authored for this content.

Actionable Clinical Workflows (21)

Step-by-step ICU Processes
Initial Hemodynamic Resuscitation & Shock Bundling

From recognizing hypoperfusion and initial crystalloid bolus to dynamic fluid responsiveness assessment and vasopressor targets.

Launch Workflow →
Vasopressor & Inotrope Initiation & Titration

From first-line norepinephrine titration to multi-agent vasopressor escalation and inotrope selection.

Launch Workflow →
Refractory Shock Support Escalation

From multi-vasopressor failure to rescue non-adrenergic agents and mechanical circulatory support.

Launch Workflow →
Hypotension

From confirming true hypotension to recognizing shock and its likely category.

Launch Workflow →

Deep-Dive Topic Destinations (8)

Reference Knowledge
Major Bleeding, Hemorrhagic Shock, & Damage Control Resuscitationhematology

The trauma lethal diamond (hypothermia, acidosis, coagulopathy, hypocalcemia), 1:1:1 massive transfusion (PROPPR trial), early TXA (CRASH-2), and TEG/ROTEM algorithms.

Explore Topic →
Blood Product Transfusion in Critical Carehematology

Patient-specific RBC transfusion thresholds, current platelet/procedural thresholds, plasma/cryoprecipitate use, and the TRALI vs TACO diagnostic matrix.

Explore Topic →
Upper Gastrointestinal Bleeding (UGIB)gi-hepatic

Risk-stratified non-variceal and variceal hemorrhage care: resuscitation, selective airway protection, individualized transfusion, PPI or portal-pressure therapy, endoscopic hemostasis, and escalation to IR/TIPS/surgery when indicated.

Explore Topic →
Lower Gastrointestinal Bleeding (LGIB)gi-hepatic

Risk stratification, selective assessment for an upper source, CTA localization of ongoing severe bleeding, endoscopic or catheter therapy, and individualized transfusion/resuscitation.

Explore Topic →
Disseminated Intravascular Coagulation (DIC) & Sepsis Coagulopathyhematology

Tissue-factor-driven coagulation activation, antithrombin/protein C depletion, PAI-1-associated fibrinolytic suppression, ISTH 2025 DIC assessment, comparison with TTP/HUS/HIT, and targeted replacement.

Explore Topic →
Therapeutic Anticoagulation & Emergency Reversal in the ICUhematology

UFH vs LMWH vs DTIs (Argatroban/Bivalirudin), anti-Xa vs aPTT monitoring, and emergency reversal (Protamine, 4F-PCC, Idarucizumab; historical andexanet evidence with current availability caveats).

Explore Topic →
Shock: Foundational Critical Care Frameworkcardiovascular

Cellular dysoxia, DO2/VO2 physiology, the 4 shock phenotypes, dynamic fluid responsiveness (PLR/PPV) vs fluid tolerance (VExUS), and vasoactive pharmacology.

Explore Topic →
Acute Kidney Injury in Critical Carerenal

Sepsis-AKI microcirculatory decoupling, KDIGO staging, Furosemide Stress Test (FST), urine microscopy, and the AEIOU dialysis threshold framework.

Explore Topic →